Enhancement by monochloramine of the development of gastric cancers in rats: A possible mechanism of Helicobacter pylori-associated gastric carcinogenesis

Journal of Gastroenterology

Volumn 32, Issue 4, 1997, Pages 435-441

  Iishi, Hiroyasu ^a   Tatsuta, Masaharu ^a   Baba, Miyako ^a   Mikuni, Tomiko ^a   Yamamoto, Reiko ^a   Iseki, Kazushige ^a   Yano, Hiroyuki ^a   Uehara, Hiroyuki ^a   Nakaizumi, Akihiko ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Gastric carcinogenesis; Helicobacter pylori; Monochloramine

Indexed keywords

AMMONIUM ACETATE; HYPOCHLORITE SODIUM; METHYLNITRONITROSOGUANIDINE; MONOCHLORAMINE; SCAVENGER; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HELICOBACTER PYLORI; INCIDENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY; STOMACH CANCER; STOMACH CARCINOGENESIS;

EID: 0030756308     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02934080     Document Type: Article

References (29)

1. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991;302:1302-1305.
2. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
3. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-1136.
4. Kikuchi S, Wada O, Nakajima T, et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995;75:2789-2793.
5. Tsujii M, Kawano S, Tsuji S, et al. Ammonia: A possible promoter in Helicobacter pylori-related gastric carcinogenesis. Cancer Lett 1992;65:15-18.
6. Tsujii M, Kawano S, Tsuji S, et al. Mechanism for ammonia-induced promotion of gastric carcinogenesis in rats. Carcinogenesis 1995;16:563-566.
7. Suzuki M, Miura S. Role of ammonia-monochloramine system in Helicobacter pylori-induced gastric mucosal injury (in Japanese with English abstract). Nippon Rinsho (Jpn J Clin Med) 1993;51:3154-3158.
8. Dekigai H, Murakami M, Kita T. Mechanism of Helicobacter pylori-associated gastric mucosal injury. Dig Dis Sci 1995; 40:1332-1339.
9. Murakami M, Asagoe K, Dekigai H, et al. Products of neutrophil metabolism increase ammonia-induced gastric mucosal damage. Dig Dis Sci 1995;40:268-273.
10. Tatsuta M, Iishi H, Yamamura H, et al. Effect of cimetidine on inhibition by tetragastrin of carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res 1988; 48:1591-1595.
11. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 1982;218:474-475.
12. Morstyn G, Hsu SM, Kinsella T, et al. Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest 1983;72:1844-1850.
13. Eastwood GL, Quimby GF. Effect of chronic cimetidine ingestion on fundic and antral epithelial proliferation in the rat. Dig Dis Sci 1983;28:61-64.
14. Thomas EL, Grisham MB, Jefferson MM. Preparation and characterization of chloramines. Methods Enzymol 1986;132:569-585.
15. Miller RG Jr. Simultaneous statistical inference. New York: McGraw-Hill, 1966.
16. Marshall BJ, Langton SR. Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet 1986;I:965-966.
17. Kawano S, Tsujii M, Fusamoto H, et al. Chronic effect of intragastric ammonia on gastric mucosal structures in rats. Dig Dis Sci 1991;36:33-38.
18. Mégraud F, Neman-Simha V, Brügmann D. Further evidence of the toxic effect of ammonia produced by Helicobacter pylori urease on human epithelial cells. Infect Immun 1992;60:1858-1863.
19. Tsujii M, Kawano S, Tsuji S, et al. Cell kinetics of mucosal atrophy in rat stomach induced by long-term administration of ammonia. Gastroenterology 1993;104:796-801.
20. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986;251:G567-G574.
21. Okamoto K, Sugie S, Ohnishi M, et al. Chemopreventive effects of taurine on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. Jpn J Cancer Res 1996;87:30-36.
22. Tanaka T, Kojima T, Kawamori T, et al. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Res 1993; 523:2775-2779.
23. Tatsuta M, Iishi H, Baba M, et al. Ornithine decarboxylase inhibitor attenuates NaCl enhancement of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis 1995;16:2107-2110.
24. Pierson HF, Fisher JM, Rabinovitz M. Modulation by taurine of the toxicity of taumustine, a compound with antitumor activity. J Natl Cancer Inst 1985;75:905-909.
25. Logani MK, Davies RE. Lipid peroxidation: Biologic effects and antioxidants - a review. Lipids 1980;15:485-495.
26. Nishikawa A, Furukawa F, Mitsui M, et al. Inhibitory effect of calcium chloride on gastric carcinogenesis in rats after treatment with N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride. Carcinogenesis 1992;13:1155-1158.
27. Wright CE, Tallan HH, Lin YY, et al. Taurine: Biological update. Annu Rev Biochem 1986;55:427-453.
28. Laidlaw SA, Dietrich MF, Lamtenzan MP, et al. Antimutagenic effects of taurine in a bacterial assay system. Cancer Res 1989;49:6600-6604.
29. Gaull GE, Wright CE, Tallan HH. Taurine in human lymphoblastoid cells: Update and role in proliferation. In: Kuriyama K, Huxtable RJ, Iwata H (eds) Sulfur amino acids, biochemical and clinical aspects. New York: Alan Liss, 1983;297-304.